is symlin a glp 1 GLP-1 receptor agonists Symlin - Diabetes In Control
Description
The prolonged half-life allows for once-weekly administration in humans [1]
Diabetologia 37 , 985993 (1994)
Lim GE, Huang GJ, Flora N, LeRoith D, Rhodes CJ, Brubaker PL
[DOI] [PubMed] [Google Scholar] 90.Reiner D.J., Mietlicki-Baase E.G., McGrath L.E., Zimmer D.J., Bence K.K., Sousa G.L., Konanur V.R., Krawczyk J., Burk D.H., Kanoski S.E., et al
Trial Emulation Suggests Real-World Impact In the retrospective cohort study, 910 patients initiating GLP-1RA were compared with 1004 patients receiving DPP-4 inhibitors, including a subset of over 590 patients with confirmed LN
